tiprankstipranks
Trending News
More News >
Zoetis (ZTS)
NYSE:ZTS
US Market
Advertisement

Zoetis (ZTS) Earnings Dates, Call Summary & Reports

Compare
3,789 Followers

Earnings Data

Report Date
Feb 17, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.41
Last Year’s EPS
1.4
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Zoetis demonstrated strong performance in international markets and Livestock segment growth, with new product approvals enhancing future prospects. However, challenges in the OA pain franchise, U.S. market pressures, and competitive dynamics in dermatology posed significant headwinds.
Company Guidance
During the Zoetis Third Quarter 2025 Earnings Call, the company provided updated guidance for the full year. Zoetis revised its full-year organic operational revenue growth range to 5.5% to 6.5%, acknowledging a more measured macro and operational environment in the second half of the year. Adjusted net income growth was also adjusted, with a new range of 5.5% to 7%, supported by disciplined cost management. The company reported a 4% organic operational revenue growth in the third quarter, driven by a 9% increase in adjusted net income. Simparica Trio's operational growth was noted at 6%, contributing to the overall 7% operational growth of the Simparica franchise, while the Companion Animal segment grew 2%, and the Livestock segment saw a robust 10% organic operational revenue growth. Zoetis emphasized its commitment to innovation and its diversified portfolio, with optimistic projections for continued growth despite some near-term challenges in the market, particularly in the U.S. Companion Animal business and therapeutic visits decline.
Organic Revenue and Net Income Growth
Zoetis reported a 4% revenue growth and 9% growth in adjusted net income on an organic operational basis.
International Segment Performance
The International segment delivered 6% organic operational revenue growth, with strong performance in both Companion Animal and Livestock segments.
Livestock Segment Growth
The Livestock segment grew 10% in organic operational revenue, marking the third consecutive year of above-market growth, driven by resilient market demand.
Simparica Franchise Success
The Simparica franchise grew 7% operationally, with a strong performance from Simparica Trio, which grew 6% operationally.
New Product Approvals
Zoetis received European approval for Portela, a long-acting monoclonal antibody for feline OA pain, and positive CVMP opinion for Lenivia in Europe.
Cost Discipline and Earnings Growth
Adjusted net income grew 5% operationally and 9% on an organic operational basis, with adjusted diluted EPS growing 7% operationally.

Zoetis (ZTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ZTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 17, 2026
2025 (Q4)
1.41 / -
1.4
Nov 04, 2025
2025 (Q3)
1.62 / 1.70
1.587.59% (+0.12)
Aug 05, 2025
2025 (Q2)
1.62 / 1.76
1.5612.82% (+0.20)
May 06, 2025
2025 (Q1)
1.41 / 1.48
1.387.25% (+0.10)
Feb 13, 2025
2024 (Q4)
1.36 / 1.40
1.2412.90% (+0.16)
Nov 04, 2024
2024 (Q3)
1.46 / 1.58
1.3616.18% (+0.22)
Aug 06, 2024
2024 (Q2)
1.49 / 1.56
1.4110.64% (+0.15)
May 02, 2024
2024 (Q1)
1.35 / 1.38
1.315.34% (+0.07)
Feb 13, 2024
2023 (Q4)
1.32 / 1.24
1.157.83% (+0.09)
Nov 02, 2023
2023 (Q3)
1.36 / 1.36
1.2112.40% (+0.15)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ZTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$144.35$124.46-13.78%
Aug 05, 2025
$151.28$145.61-3.75%
May 06, 2025
$156.99$148.85-5.19%
Feb 13, 2025
$172.12$163.26-5.15%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zoetis (ZTS) report earnings?
Zoetis (ZTS) is schdueled to report earning on Feb 17, 2026, Before Open (Confirmed).
    What is Zoetis (ZTS) earnings time?
    Zoetis (ZTS) earnings time is at Feb 17, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ZTS EPS forecast?
          ZTS EPS forecast for the fiscal quarter 2025 (Q4) is 1.41.

            Zoetis (ZTS) Earnings News

            Zoetis (NYSE:ZTS) Jumps on Q3 Beats
            Premium
            Market News
            Zoetis (NYSE:ZTS) Jumps on Q3 Beats
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis